KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) FCF Margin (2019 - 2026)

GoodRx Holdings' FCF Margin history spans 7 years, with the latest figure at 9.39% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 1306.0% to 9.39% in Q4 2025 year-over-year; TTM through Dec 2025 was 12.22%, a 1083.0% decrease, with the full-year FY2025 number at 12.22%, down 1083.0% from a year prior.
  • FCF Margin hit 9.39% in Q4 2025 for GoodRx Holdings, down from 10.53% in the prior quarter.
  • Over the last five years, FCF Margin for GDRX hit a ceiling of 44.28% in Q3 2024 and a floor of 1.73% in Q4 2023.
  • Historically, FCF Margin has averaged 15.88% across 5 years, with a median of 12.53% in 2021.
  • Biggest five-year swings in FCF Margin: surged 3403bps in 2024 and later tumbled -3375bps in 2025.
  • Tracing GDRX's FCF Margin over 5 years: stood at 11.11% in 2021, then fell by -18bps to 9.09% in 2022, then tumbled by -81bps to 1.73% in 2023, then skyrocketed by 1196bps to 22.45% in 2024, then tumbled by -58bps to 9.39% in 2025.
  • Business Quant data shows FCF Margin for GDRX at 9.39% in Q4 2025, 10.53% in Q3 2025, and 24.22% in Q2 2025.